Collectively, our study provides new insights into SDC4 as a previously undisclosed promising therapeutic target against HCC, and SDC4/DDX23 signaling axis plays a fundamental role in suppressing HCC growth and progression. The gene discussed is SDC4; the disease is hepatocellular carcinoma.